2 Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR.

The changing face of low-risk prostate cancer: trends in

clinical presentation and primary management.

J Clin Oncol

2004;

: 2141–2149.

3 Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM

et al.

Annual report to the nation on the status of cancer,

1975-2005, featuring trends in lung cancer, tobacco use, and

tobacco control.

J Natl Cancer Inst

2008;

100

: 1672–1694.

4 Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term

biochemical disease-free and cancer-specific survival following

anatomic radical retropubic prostatectomy. The 15-year Johns

Hopkins experience.

Urol Clin North Am

2001;

: 555–565.

5 Althof SE. Quality of life and erectile dysfunction.

Urology

2002;

: 803–810.

6 Rosen RC. Quality of life assessment in sexual dysfunction

trials.

Int J Impot Res

1998;

(Suppl 2): S21–S23; discussion

S24–26.

7 Kaminetsky JC, Depko AJ, Stroberg P, Buvat J, Tseng LJ,

Stecher VJ. In men with erectile dysfunction, satisfaction with

quality of erections correlates with erection hardness, treat-

ment satisfaction, and emotional well-being.

J Sex Med

2009;

: 800–808.

8 Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM,

Chartier-Kastler E. How urologists manage erectile dysfunc-

tion after radical prostatectomy: a national survey (REPAIR) by

the French urological association.

J Sex Med

2008;

: 448–457.

9 Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical

prostatectomy pharmacological penile rehabilitation: practice

patterns among the international society for sexual medicine

practitioners.

J Sex Med

2009;

: 2032–2038.

10 Burnett AL. Rationale for cavernous nerve restorative therapy

to preserve erectile function after radical prostatectomy.

Urology

2003;

: 491–497.

11 Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS,

Champion HC

et al.

Cavernous neurotomy causes hypoxia and

fibrosis in rat corpus cavernosum.

J Androl

2003;

: 239–245.

12 User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT.

Penile weight and cell subtype specific changes in a post-

radical prostatectomy model of erectile dysfunction.

J Urol

2003;

169

: 1175–1179.

13 Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G

et al.

Apoptosis in the rat penis after penile denervation.

J Urol

1997;

158

: 626–630.

14 Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves

intracorporeal smooth muscle after radical retropubic prosta-

tectomy.

J Urol

2004;

171

(2 Part 1): 771–774.

15 Muller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K,

Paduch D

et al.

The effect of hyperbaric oxygen therapy on

erectile function recovery in a rat cavernous nerve injury

model.

J Sex Med

2008;

: 562–570.

16 Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link

RE, Lipshultz LI

et al.

The female factor: predicting compli-

ance with a post-prostatectomy erectile preservation program.

J Sex Med

2010;

: 3659–3665.

17 McCullough AR, Levine LA, Padma-Nathan H. Return of

nocturnal erections and erectile function after bilateral nerve-

sparing radical prostatectomy in men treated nightly with

sildenafil citrate: subanalysis of a longitudinal randomized

double-blind placebo-controlled trial.

J Sex Med

2008;

476–484.

18 Padma-Nathan H MA, Giuliano F, Toler SM, Wohlhuter C,

Shpilsky AB. Post-operative nightly administration of silde-

nafil citrate significantly improves the return of normal

sponta-neous erectile function after bilateral nerve-sparing

radical prostatectomy.

J Urol

2003;

169

(Suppl): 375–376.

19 Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI,

Siegel R, Montorsi F

et al.

Randomized, double-blind,

placebo-controlled study of postoperative nightly sildenafil

citrate for the prevention of erectile dysfunction after bilateral

nerve-sparing radical prostatectomy.

Int J Impot Res

2008;

479–486.

20 Bannowsky A, Schulze H, van der Horst C, Hautmann S,

Junemann KP. Recovery of erectile function after nerve-

sparing radical prostatectomy: improvement with nightly

low-dose sildenafil.

BJU Int

2008;

101

: 1279–1283.

21 Montorsi F, McCullough A. Efficacy of sildenafil citrate in

men with erectile dysfunction following radical prostatect-

omy: a systematic review of clinical data.

J Sex Med

2005;

658–667.

22 Mulhall JP. The role and structure of a postradical prostatect-

omy penile rehabilitation program.

Curr Urol Rep

2009;

219–225.

23 Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M

et al.

Effect of nightly versus on-demand vardenafil on recovery

of erectile function in men following bilateral nerve-sparing

radical prostatectomy.

Eur Urol

2008;

: 924–931.

24 Mulhall JP, Muller A, Donohue JF, Mullerad M, Kobylarz K,

Paduch DA

et al.

The functional and structural consequences

of cavernous nerve injury are ameliorated by sildenafil citrate.

J Sex Med

2008;

: 1126–1136.

25 Mulhall JP, Graydon RJ. The hemodynamics of erectile

dysfunction following nerve-sparing radical retropubic pros-

tatectomy.

Int J Impot Res

1996;

: 91–94.

26 Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L,

Barbieri L

et al.

Recovery of spontaneous erectile function

after nerve-sparing radical retropubic prostatectomy with

and without early intracavernous injections of alprostadil:

results of a prospective, randomized trial.

J Urol

1997;

158

1408–1410.

27 Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters

et al.

Erectile dysfunction after radical prostatectomy:

hemodynamic profiles and their correlation with the recovery

of erectile function.

J Urol

2002;

167

: 1371–1375.

28 Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF,

Nolten WE

et al.

Treatment of men with erectile dysfunction

with transurethral alprostadil. Medicated Urethral System for

Erection (MUSE) Study Group.

N Engl J Med

1997;

336

:1–7

29 Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB,

Kadesky KT

et al.

Disappointing initial results with transur-

ethral alprostadil for erectile dysfunction in a urology practice

setting.

J Urol

1998;

160

(6 Part 1): 2041–2046.

30 Raina R, Agarwal A, Zaramo CE, Ausmundson S, Mansour D,

Zippe CD. Long-term efficacy and compliance of MUSE for

erectile dysfunction following radical prostatectomy: SHIM

(IIEF-5) analysis.

Int J Impot Res

2005;

: 86–90.

31 McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR,

Engel JD. Recovery of erectile function after nerve sparing

radical prostatectomy and penile rehabilitation with nightly

intraurethral alprostadil versus sildenafil citrate.

J Urol

2010;

183

: 2451–2456.

32 Magheli A, Burnett AL. Erectile dysfunction following

prostatectomy: prevention and treatment.

Nat Rev Urol

2009;

: 415–427.

33 Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal

A. Management of erectile dysfunction following radical

prostatectomy.

Curr Urol Rep

2001;

: 495–503.

34 Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC,

Montague DK

et al.

Early use of vacuum constriction device

following radical prostatectomy facilitates early sexual activ-

ity and potentially earlier return of erectile function.

Int J

Impot Res

2006;

: 77–81.

35 Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P

et al.

A pilot study on the early use of the vacuum erection

device after radical retropubic prostatectomy.

BJU Int

2007;

100

: 858–862.

36 Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective

measurement of the effectiveness, therapeutic success and

dynamic mechanisms of the vacuum device.

Br J Urol

1995;

: 786–791.

37 Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use

of an erectogenic pharmacotherapy regimen following radical

prostatectomy improves recovery of spontaneous erectile

function.

J Sex Med

2005;

: 532–540; discussion 540–532.

38 Wang R. Penile rehabilitation after radical prostatectomy:

where do we stand and where are we going?

J Sex Med

2007;

(4 Part 2): 1085–1097.

Review and treatment protocol: erectile preservation for RP patients

DJ Moskovic

et al

191

International Journal of Impotence Research